Literature DB >> 7863219

Opposite functions for two classes of genes of the human carcinoembryonic antigen family.

C P Stanners1, L DeMarte, M Rojas, P Gold, A Fuks.   

Abstract

The human carcinoembryonic antigen (CEA) family can be divided into two subgroups according to the means of anchorage of member glycoproteins to the cell membrane: glycophosphatidyl inositol (GPI) linkage and transmembrane linkage. The GPI-linked members tend to be up-regulated in human tumours, whereas the transmembrane-linked members tend to be down-regulated. Thus the question as to whether the GPI members could be formally considered to function as oncogenes and the transmembrane members as tumour suppressors deserves consideration. Members of both subgroups function in vitro as intercellular adhesion molecules, but the characteristics of this adhesion, including temperature and divalent-cation dependence, differ markedly between the groups. Even the mechanism of intermolecular adhesion appears to differ fundamentally in that GPI-linked CEA-CEA binding involves a double reciprocal bonding between two domains, whereas transmembrane-linked biliary glycoprotein (BGP)-BGP binding requires only one domain. Finally, the ectopic expression of CEA in myoblasts can block myogenic differentiation leaving the cells with the ability to divide, while expression of BGP does not affect or may even accelerate myogenic differentiation. These differences in phenotypic effects in vitro thus mirror the differences observed in expression in tumours and support the view that the GPI and transmembrane groups have opposite effects on cells in relation to the malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7863219     DOI: 10.1159/000217925

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

1.  Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophils.

Authors:  M M Estabrook; D Zhou; M A Apicella
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 2.  Adhesion or anti-adhesion in cancer: what matters more?

Authors:  S Jothy; S B Munro; L LeDuy; D McClure; O W Blaschuk
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

3.  Evolution of a tumorigenic property conferred by glycophosphatidyl-inositol membrane anchors of carcinoembryonic antigen gene family members during the primate radiation.

Authors:  Fakhraddin Naghibalhossaini; Anne D Yoder; Martin Tobi; Clifford P Stanners
Journal:  Mol Biol Cell       Date:  2007-02-07       Impact factor: 4.138

4.  Improving biosensing activity to carcinoembryonic antigen with orientated single domain antibodies.

Authors:  Jinny L Liu; Deepa Raghu; George P Anderson; Ellen R Goldman; Joseph A Christodoulides; Marc P Raphael
Journal:  Heliyon       Date:  2017-12-28

Review 5.  CEA adhesion molecules: multifunctional proteins with signal-regulatory properties.

Authors:  B Obrink
Journal:  Curr Opin Cell Biol       Date:  1997-10       Impact factor: 8.382

6.  Cutoff values of preoperative s-CEA levels for predicting survivals after curative resection of colorectal cancer.

Authors:  In Ja Park; Hee Cheol Kim; Chang Sik Yu; Jang Hak Yoo; Jin Cheon Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

7.  Large-cell carcinoma of the lung with a remarkable preoperative elevation of serum carcinoembryonic antigen level.

Authors:  Naotaka Uchida; Shunsuke Fukino; Wataru Kodama; Nobuyuki Tamai; Tohru Hiroe; Tamito Fukata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-05

8.  Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells.

Authors:  Keith M Skubitz; Amy P N Skubitz
Journal:  J Transl Med       Date:  2008-12-10       Impact factor: 5.531

9.  The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study.

Authors:  Guojun Tong; Wei Xu; Guiyang Zhang; Jian Liu; Zhaozheng Zheng; Yan Chen; Pingping Niu; Xuting Xu
Journal:  Cancer Med       Date:  2018-10-09       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.